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Introduction: Sepsis is a systemic infection that can rapidly progress into multi organ failure and 
shock if left untreated. Previous studies have demonstrated the utility of point of care ultrasound 
(POCUS) in the evaluation of patients with sepsis. However, limited data exists on the evaluation of 
the tricuspid annular plane of systolic excursion (TAPSE) in patients with sepsis.
 
Methods: We prospectively enrolled patients who presented to the emergency department (ED) 
with concern for severe sepsis or septic shock in a pilot study. In patients that screened positive, the 
treating physician then performed POCUS to measure the TAPSE value. We compared the intensive 
care unit (ICU) admission rate, hospital length of stay, and morbidity with their respective TAPSE 
values. 
Results: We enrolled 24 patients in the study. Eight patients had TAPSE values less than 16 
millimeters (mm), two patients had TAPSE values between 16mm-20mm, and fourteen patients had 
TAPSE values greater than 20mm. There was no statistically significant association between TAPSE 
levels and ICU admission (p=0.16), or death (p=0.14). The difference of length of stay (LOS) was not 
statistically significant in case of hospital LOS (p= 0.72) or ICU LOS. 
Conclusion: Our pilot data did not demonstrate a correlation between severe sepsis or septic 
shock and TAPSE values. This may be due to several factors including patient comorbidities, strict 
definitions of sepsis and septic shock, as well as the absence of septic cardiomyopathy (SCM) in 
patients with sepsis and septic shock. Future large-scale studies are needed to determine if TAPSE 
can be beneficial in the ED evaluation of patients with concern for SCM. [West J Emerg Med. 
2019;21(2)X-X.]
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INTRODUCTION
Sepsis is a systemic infection that can rapidly progress 
into multi organ failure and shock if left untreated. As a 
disease process, sepsis carries up to a 25% mortality rate 
and affects millions of patients annually.1 Most commonly, 
a bacterial infection causes a systemic inflammatory 
cascade leading to a spectrum of physiologic changes.2,3 
The sequelae of sepsis can lead to significant morbidity and 
mortality in the setting of delayed treatment. As such, there 
has been increasing pressure on emergency departments 
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Population Health Research Capsule
What do we already know about this issue?
Sepsis is a systemic infection that can rapidly 
progress if left untreated. No studies have 
evaluated the tricuspid annular plane of systolic 
excursion (TAPSE) in patients with sepsis.
What was the research question?
Can TAPSE values be useful in evaluating 
patients with sepsis and septic shock?
What was the major finding of the study?
Our pilot data did not demonstrate a 
correlation between severe sepsis or septic 
shock and TAPSE values.
How does this improve population health?
Point-of-care ultrasound is useful in 
evaluation of patients with sepsis. However, 
TAPSE may not be predictive of outcomes for 
patients with sepsis or septic shock.
(ED) in the United States to rapidly initiate antibiotics 
and resuscitative care to patients in early stages of the 
disease process. Currently, patients are screened using 
vital sign abnormalities, basic laboratory data, and clinical 
gestalt. Patients with presumed sepsis are often empirically 
resuscitated with intravenous fluids and broad-spectrum 
antibiotics.4,5 
Septic cardiomyopathy (SCM) is defined as a reversible 
cardiac dysfunction that results in decreased ejection 
fraction.6 In patients with sepsis, the presence of septic 
cardiomyopathy (SCM) is known to result in significant 
negative clinical outcomes and a three- to four-fold increase 
in mortality.6 Despite the success of sepsis algorithms, a 
standardized treatment (such as a 30 cubic centimeters per 
kilogram [cc/kg] fluid bolus) may have uniquely negative 
consequences in patients with pre-existing conditions such as 
SCM, congestive heart failure, or pulmonary hypertension. 
SCM occurs via several different mechanisms. This includes 
tachycardia, hypotension and eventual end organ damage.7 
While most literature regarding the prognostic implications 
of SCM has focused on left ventricular function, few studies 
have evaluated the association between right ventricular 
dysfunction and sepsis.8,9 Furthermore, accurately studying 
the effects of sepsis on SCM is a challenging task due a broad 
range of variables including systolic vs diastolic ventricular 
impairment, cardiac output, and end-organ tissue injury.10 The 
characterization of sepsis in SCM and alternative management 
strategies has great potential to positively impact morbidity 
and mortality in a population predisposed to poor outcomes in 
the setting of pre-existing conditions.
Previous studies have demonstrated the utility of 
point of care ultrasound (POCUS) in the evaluation of 
patients with sepsis.11,12 However, limited data exists on 
the evaluation of POCUS for septic cardiomyopathy. 
There are no specific or sensitive sonographic signs for 
identifying sepsis or septic cardiomyopathy (SCM) other 
than those associated with infection at a specific site. Most 
literature describes SCM in terms of a relationship to left 
ventricular dysfunction.13 However, measurements of left 
ventricular function do not explain the relationship between 
the high preload from resuscitative efforts. Our study aims 
to assess the right ventricle in patients with severe sepsis. 
Specifically, we aim to evaluate tricuspid annular plane 
systolic excursion (TAPSE), which is an effective indirect 
method of evaluating right ventricular (RV) function.14 The 
American Society of Echocardiography recommends the 
use of TAPSE as a quantitative method of estimating RV 
function. Additionally, previous studies have demonstrated 
that emergency physicians (EPs) are capable of obtaining 
TAPSE measurements in ED patients.15,16 
The objective of this pilot study is to evaluate the 
relationship between RV dysfunction as measured by 
POCUS obtained TAPSE values in patients presenting to the 
ED with concern for severe sepsis and septic shock. 
MATERIALS AND METHODS
Study Design and Settings
We performed a prospective, observational single-site pilot 
study using a convenience sample of patients who presented to 
the ED between March 2018 and February 2019. Patients were 
enrolled in an urban university hospital ED, which supports 
an emergency medicine (EM) residency training program as 
well as an EM ultrasound fellowship. The annual ED census 
consists of approximately 57,000 patient visits annually with 
an ethnically and economically diverse patient population. The 
study was approved by the University of California institutional 
review board and follows the Standards for Reporting of 
Diagnostic Accuracy Studies guidelines.
Selection of Participants
Research associates monitored the ED track board 
for potential patients daily between the hours of 8:00 am 
and 12:00 midnight. Patients were eligible for inclusion if 
they were at least 18 years old, able to provide written and 
verbal consent in English or Spanish, and were undergoing 
evaluation for sepsis and septic shock. All laboratory tests 
and imaging studies were performed at the discretion of 
the treating physician. Patients were excluded if they were 
pregnant, incarcerated, mechanically ventilated prior to initial 
evaluation, unable to provide medical consent, or did not 
meet inclusion criteria. Patients were also excluded if they 
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had a history of pulmonary hypertension, known pulmonary 
embolism, or heart failure. The research associates obtained 
informed and written consent from eligible patients after 
discussion of the study with the treating physician.
Study Protocol
In patients that screened positive for severe sepsis or 
septic shock, the treating physician approached the patient 
for enrollment in the study. Screening for patients was 
based on the Third International Consensus Definitions for 
Sepsis and Septic Shock, which includes fever, tachycardia, 
and hypotension. Screening criteria included at least two 
of the following: temperature > 38 C or < 36 C, heart rate 
> 90 beats per minute, respiratory rate > 20 breaths per 
minute or partial pressure of carbon dioxide (PaCO2) < 32 
millimeters of mercury (mmHg), white blood cell (WBC) 
count > 12,000/mm³, < 4,000/mm³, or > 10% bands, and a 
suspected or present source of infection. For patients with 
severe sepsis or septic shock, additional criteria included 
hypotension despite adequate fluid resuscitation or evidence 
of ≥ 2 organs failing.5
Any patient that met criteria was approached for 
enrollment in the study. Following verbal and written 
consent, the research team collected data using a systematic 
approach on a standard data abstraction sheet. Collected 
data included general demographics such as age and gender, 
along with history of heart failure, pulmonary hypertension, 
pulmonary embolism, chronic obstructive pulmonary 
disease, hypertension, and smoking. Initial vital signs were 
also collected, along with POCUS measurements in real 
time during evaluation. Following enrollment and treatment, 
retrospective data was collected including length of hospital 
stay (LOS), intensive care unit (ICU) admittance, incidence 
of respiratory failure, and/or mortality.
TAPSE Protocol 
Following consent, the treating emergency physician 
then performed POCUS to measure the TAPSE value prior 
to obtaining any laboratory results, imaging test results, 
or treatment. TAPSE values were obtained using Mindray 
TE7 (Mindray North America, Mahwah, NJ) ultrasound 
machines with a phased array transducer in the cardiac 
software setting. All patients were placed in the left lateral 
decubitus position to properly obtain an apical 4-chamber 
view of the heart. An M-mode sampling spike was placed 
at the right lateral border of the heart at the tricuspid valve 
annulus, which generated simultaneous live B and M-mode 
active tracings. A TAPSE value was obtained by measuring 
the vertical height between the peak and trough in a single 
cardiac cycle to determine the apex to base shortening.17 
Patients were then differentiated into three groups. Groups 
included TAPSE values less than 16 mm, TAPSE 16 mm-20 
mm, and TAPSE >20 mm. 
A total of 14 unique physicians collected TAPSE 
measurements. This included EM attending physicians, 
resident physicians, and emergency medicine ultrasound 
fellows. Prior to the enrollment of patients in the study, 
all EM physicians underwent a 30-minute didactic lecture 
followed by supervised hands-on scanning of three healthy 
volunteer adult models. All practitioners were required to 
demonstrate the ability to obtain an apical 4-chamber view 
and correctly take a TAPSE measurement on three models 
prior to enrolling patients. All POCUS images were archived 
and reviewed by the ED ultrasound director to confirm 
appropriate image quality and accurate measurements. 
Statistical analysis
Frequencies are represented as count (%) and 
continuous variables as mean ± standard deviation (SD). Chi 
square test for trend was used to examine the distribution of 
death and ICU admission per TAPSE levels. We compared 
the hospital length of stay and the ICU length of stay with 
their respective TAPSE values using the Kruskal-Wallis test. 
The distribution of TAPSE value was examined by using the 
Kolmogorov-Smirnov statistical test. IBM SPSS Statistics 
for Windows version 25 was used for data analysis.
 
RESULTS
32 patients were approached for enrollment in the study. 
Eight patients were excluded from the final data analysis: 
two patients declined to participate, five patients reported 
a history of heart failure, and one patient had a history of 
pulmonary embolism and was on anticoagulation. A total of 
24 patients were enrolled in the study. Four patients (16.7%) 
were female and 20 patients (83.3%) were male. The mean 
age of the enrolled patients was 56 ± 18. See Table 1 for full 
patient characteristics. 
Patients were organized into three different TAPSE 
groups. Eight patients had TAPSE values less than 16 mm, 
two patients had TAPSE values between 16 mm-20 mm, and 
fourteen patients had TAPSE values greater than 20 mm. 
The distribution of TAPSE value was not far from normal 
(P=0.20). The mean TASPE value was 20.8 with SD of 6.68 
(Range: 9.6-34.2). In the TAPSE group less than 16 mm, 
two patients (25%) were admitted to the ICU and none had 
mortality during admission. In the TAPSE group 16mm-
20mm, one (50%) was admitted to the ICU and none had 
mortality during admission. In the TAPSE group greater 
than 20mm, 11 (45.8%) were admitted to the ICU and three 
(21.4%) had mortality during admission. There was not a 
statistically significant association between TAPSE levels 
and ICU admission (p=0.16) or death (p=0.14).
The average hospital length of stay (LOS) for each 
group was 99±51, 184±92 and 132±57 hours respectively. 
The average ICU LOS for each group was 34±49, 96±48 
and 51±38 hours respectively. The difference of LOS was 
not statistically significant neither in case of hospital LOS 
(p= 0.72) nor ICU LOS (p=0.75).
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DISCUSSION
Severe sepsis and septic shock are commonly evaluated 
and treated in the ED. However, currently there are no gold 
standard ultrasound findings that can be used to identify 
severe sepsis or SCM. Our study aims to determine if there 
is a role for the assessment of TAPSE in patients with severe 
sepsis and septic shock. Our pilot data does not demonstrate 
any significant difference between ICU admission or mortality 
based on ED measured TAPSE values. On retrospective 
review of physician charting, all patients received a 
resuscitative fluid bolus in addition to antibiotics. Based on 
previous studies, we divided our patients into three categories 
(TAPSE value 16 mm or less, TAPSE value 16 mm to 20 
mm and TAPSE value greater than 20mm). Although we 
excluded patients with known heart failure and other cardiac 
co-morbidities, other factors including age may also play a 
role in TAPSE values distinct from the effects of severe sepsis 
or septic shock. The lack of gold standard radiologic findings 
specific to sepsis combined with the broad definition of sepsis 
made establishing TAPSE cutoffs difficult. Additionally, 
altering the measurement cutoffs for RV dysfunction in our 
study did not yield statistically significant results. 
A previous study by Daley et al. evaluated TAPSE values 
in patients with pulmonary embolism and used a cutoff of 
20 mm to yield a 72% sensitivity for detecting pulmonary 
embolism.15 Other literature uses 17 mm as a threshold for 
right ventricular dysfunction (RVD).18 As such, there is no 
consensus on what TAPSE value predicts worsening or 
improving right ventricular function or precludes its utility in 
clinical decision making when evaluating patients with severe 
sepsis or septic shock. To our knowledge, no previous studies 
have evaluated the relationship between sepsis or septic 
cardiomyopathy and TAPSE values. Thus, there are no defined 
numerical values where TAPSE becomes clinically significant 
in patients with severe sepsis, septic shock, or SCM. 
The most challenging aspect of the research in defining 
the role of TAPSE in SCM was defining a patient population 
with sepsis based on non-specific markers, such as vitals, 
basic laboratory data, and clinical judgement. Recent efforts 
have been focused on eliminating the Systemic Inflammatory 
Response Syndrome (SIRS) requirement, as fever, 
tachycardia, blood pressure, and white blood cell count are too 
broad to be applied to critically ill patients.19 Using standard 
SIRS as criteria, we captured a broad range of infectious 
sources as well as a range disease pathogenicity. Additionally, 
we were challenged in attempting to control for the numerous 
comorbidities with known associations that impact sepsis 
and shock.20 Other definitions of sepsis including the quick 
sequential organ failure assessment (qSOFA) was also 
considered. However, neither definition is narrow enough. 
This broad definition of sepsis leads to understanding the 
condition as a spectrum of disease. Recruiting patients for our 
study also proved difficult due to comorbidities in this patient 
population. Eight patients (25%) were excluded from data 
analysis due to existing cardiovascular conditions that may 
have affected their TAPSE measurement.  
Furthermore, patients who meet SIRS criteria and are 
ultimately diagnosed with severe sepsis or even septic shock 
may not exhibit septic cardiomyopathy. While using standards 
to identify and quickly evaluate patients with infection is 
useful, the correlation between defined sepsis and SCM is 
unclear and warrants future projects. The evaluation of the 
right ventricle in an otherwise healthy patient with severe 
sepsis or septic shock may not demonstrate signs of SCM 
based on anatomy and physiology. Furthermore, additional 
values traditionally evaluated in patients with SCM may not 
always correlate with TAPSE values. This includes lactic 
acidosis and troponin.21 Further studies are warranted to 
assess the value of TAPSE measurements in select patient 
populations such as sepsis or SCM. Based on our pilot data, 
future large-scale studies are needed to evaluate right heart 
findings in comparison to global cardiac dysfunction in 
patients with confirmed SCM to better understand the role of 
TAPSE in this patient population. 
 
LIMITATIONS
This study has several limitations. A small number of 
patients (24) were enrolled utilizing a convenience sample 
population. This may have introduced selection bias and 
decreased validity. A single site was used, and the findings 
from this site may not be generalizable to other patient 
populations. SIRS criteria was used to identify patients with 
sepsis and septic shock. The variability of sepsis and septic 
Count (%)
Gender Female 4 (16.7%)
Male 20 (83.3%)
HTN No 14 (58.3%)
Yes 10 (41.7%)
Smoking No 16 (66.7%)
Yes 8 (33.3%)
3+ SIRS criteria No 12 (52.2%)
Yes 11 (47.8%)
ICU admission No 10 (41.6%)
Yes 14 (58.3%)
Mortality No 21 (87.5%)
Yes 3 (12.5%)
Age 56+18 Range: 19-87; Median=60
Hospital LOS 118+74 Range: 0-312; Median=12
ICU LOS 38+48 Range: 0-144; Median=24
Table 1. Characteristics of study sample.
HTN, hypertension; SIRS, systemic inflammatory response 
syndrome; ICU, intensive care unit; LOS, length of stay. 
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shock allows a broad category of patients to be diagnosed with 
such conditions making it difficult to study the immediate 
relationship between TAPSE value and outcomes for these 
patients. Our study did not seek to determine the amount of 
training required for proficiency in obtaining or interpreting 
TAPSE values. Measurements may be affected by operator 
experience leading to a greater impact on a study, especially 
with a smaller sample size. Interrater reliability was not 
measured in this study. 
 
CONCLUSIONS
Our pilot data did not demonstrate a correlation between 
severe sepsis or septic shock and TAPSE values. This may be 
due to several factors including patient comorbidities, strict 
definitions of sepsis and septic shock, as well as the absence of 
SCM in patients with sepsis and septic shock. Future large-scale 
studies are needed to determine if TAPSE can be beneficial in 
the ED evaluation of patients with concern for SCM. 
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